Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Lartey SL"'
Autor:
Waldock J; Influenza Resource Centre, Vaccines, Science Research & Innovation, Medicines and Healthcare Products Regulatory Agency, Potters Bar, United Kingdom., Remarque EJ; Department of Parasitology, Biomedical Primate Research Centre, Rijswijk, Netherlands., Zheng L; Department of Research and Development, Sanofi, Marcy L'Etoile, France., Ho S; Respiratory Viruses Unit, UK Health Secruity Agency, Colindale, United Kingdom., Hoschler K; Respiratory Viruses Unit, UK Health Secruity Agency, Colindale, United Kingdom., Neumann B; Section for Viral Vaccines, Virology Division, Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, Langen, Germany., Sediri-Schön H; Section for Viral Vaccines, Virology Division, Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, Langen, Germany., Trombetta CM; Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy., Montomoli E; Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy., Marchi S; Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy., Lapini G; Vismederi srl, Siena, Italy., Zhou F; Influenza Centre, Department of Clinical Sciences, University of Bergen, Bergen, Norway., Lartey SL; Influenza Centre, Department of Clinical Sciences, University of Bergen, Bergen, Norway., Cox RJ; Influenza Centre, Department of Clinical Sciences, University of Bergen, Bergen, Norway., Facchini M; World Health Organisation (WHO) National Influenza Centre, Department of Infectious, Parasitic and Immune-mediated Diseases, Istituto Superiore di Sanità, Rome, Italy., Castrucci MR; World Health Organisation (WHO) National Influenza Centre, Department of Infectious, Parasitic and Immune-mediated Diseases, Istituto Superiore di Sanità, Rome, Italy., Friel D; GSK, Wavre, Belgium., Ollinger T; GSK, Wavre, Belgium., Caillet C; Department of Research and Development, Sanofi, Marcy L'Etoile, France., Music N; Seqirus, Cambridge, MA, United States., Palladino G; Seqirus, Cambridge, MA, United States., Engelhardt OG; Influenza Resource Centre, Vaccines, Science Research & Innovation, Medicines and Healthcare Products Regulatory Agency, Potters Bar, United Kingdom.
Publikováno v:
Frontiers in immunology [Front Immunol] 2023 Apr 18; Vol. 14, pp. 1155552. Date of Electronic Publication: 2023 Apr 18 (Print Publication: 2023).
Autor:
Waldock J; Vaccines, Science Research & Innovation, Medicines and Healthcare Products Regulatory, Potters Bar, United Kingdom., Weiss CD; Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, United States., Wang W; Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, United States., Levine MZ; Influenza Division, Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Atlanta, GA, United States., Jefferson SN; Influenza Division, Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Atlanta, GA, United States., Ho S; Respiratory Viruses Unit, UK Health Security Agency, Colindale, United Kingdom., Hoschler K; Respiratory Viruses Unit, UK Health Security Agency, Colindale, United Kingdom., Londt BZ; hVivo The Queen Mary Bioenterprises (QMB) Innovation, London, United Kingdom., Masat E; hVivo The Queen Mary Bioenterprises (QMB) Innovation, London, United Kingdom., Carolan L; World Health Organisation (WHO) Collaborating Centre for Reference and Research on Influenza, Royal Melbourne Hospital, at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia., Sánchez-Ovando S; World Health Organisation (WHO) Collaborating Centre for Reference and Research on Influenza, Royal Melbourne Hospital, at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.; Department of Infectious Diseases, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia., Fox A; World Health Organisation (WHO) Collaborating Centre for Reference and Research on Influenza, Royal Melbourne Hospital, at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.; Department of Infectious Diseases, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia., Watanabe S; Center for Influenza and Respiratory Virus Research, National Institute of Infectious Diseases: Musashi-Murayama, Tokyo, Japan., Akimoto M; Center for Influenza and Respiratory Virus Research, National Institute of Infectious Diseases: Musashi-Murayama, Tokyo, Japan., Sato A; Center for Influenza and Respiratory Virus Research, National Institute of Infectious Diseases: Musashi-Murayama, Tokyo, Japan., Kishida N; Center for Influenza and Respiratory Virus Research, National Institute of Infectious Diseases: Musashi-Murayama, Tokyo, Japan., Buys A; Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases (NICD) of the National Health Laboratory Services, Johannesburg, South Africa., Maake L; Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases (NICD) of the National Health Laboratory Services, Johannesburg, South Africa., Fourie C; Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases (NICD) of the National Health Laboratory Services, Johannesburg, South Africa., Caillet C; Department of Research and Development, Sanofi, Lyon, France., Raynaud S; Department of Research and Development, Sanofi, Lyon, France., Webby RJ; Department of Infectious Diseases, St Jude Children's Research Hospital, Memphis, TN, United States., DeBeauchamp J; Department of Infectious Diseases, St Jude Children's Research Hospital, Memphis, TN, United States., Cox RJ; Influenza Centre, Department of Clinical Sciences, University of Bergen, Bergen, Norway., Lartey SL; Influenza Centre, Department of Clinical Sciences, University of Bergen, Bergen, Norway., Trombetta CM; Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy., Marchi S; Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy., Montomoli E; Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy., Sanz-Muñoz I; National Influenza Centre of Valladolid, Instituto de Estudios de Ciencias de la Salud de Castilla y León (ICSCYL), Edificio Rondilla, Hospital Clínico Universitario de Valladolid, Valladolid, Spain., Eiros JM; National Influenza Centre of Valladolid, Instituto de Estudios de Ciencias de la Salud de Castilla y León (ICSCYL), Edificio Rondilla, Hospital Clínico Universitario de Valladolid, Valladolid, Spain., Sánchez-Martínez J; National Influenza Centre of Valladolid, Instituto de Estudios de Ciencias de la Salud de Castilla y León (ICSCYL), Edificio Rondilla, Hospital Clínico Universitario de Valladolid, Valladolid, Spain., Duijsings D; Viroclinics, Clinical Virology Services, Rotterdam, Netherlands., Engelhardt OG; Vaccines, Science Research & Innovation, Medicines and Healthcare Products Regulatory, Potters Bar, United Kingdom.
Publikováno v:
Frontiers in immunology [Front Immunol] 2023 Feb 28; Vol. 14, pp. 1129765. Date of Electronic Publication: 2023 Feb 28 (Print Publication: 2023).
Autor:
Ertesvåg NU; Influenza Centre, Department of Clinical Science, University of Bergen, Bergen, Norway. nina.ertesvag@uib.no., Cox RJ; Influenza Centre, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Microbiology, Haukeland University Hospital, Bergen, Norway., Lartey SL; Influenza Centre, Department of Clinical Science, University of Bergen, Bergen, Norway., Mohn KG; Influenza Centre, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Medicine, Haukeland University Hospital, Bergen, Norway., Brokstad KA; Influenza Centre, Department of Clinical Science, University of Bergen, Bergen, Norway., Trieu MC; Influenza Centre, Department of Clinical Science, University of Bergen, Bergen, Norway. chi.trieu@uib.no.
Publikováno v:
NPJ vaccines [NPJ Vaccines] 2022 Jun 24; Vol. 7 (1), pp. 67. Date of Electronic Publication: 2022 Jun 24.
Autor:
Waldock J; National Institute for Biological Standards and Control, Potters Bar, United Kingdom., Zheng L; Sanofi Pasteur, Swiftwater, Pennsylvania, USA., Remarque EJ; Biomedical Primate Research Centre, Rijswijk, The Netherlands., Civet A; Quinten, Paris, France., Hu B; Sanofi Pasteur, Swiftwater, Pennsylvania, USA., Jalloh SL; Influenza Centre, Department of Clinical Sciences, University of Bergen, Bergen, Norway., Cox RJ; Influenza Centre, Department of Clinical Sciences, University of Bergen, Bergen, Norway., Ho S; Public Health Englandgrid.271308.f, Colindale, United Kingdom., Hoschler K; Public Health Englandgrid.271308.f, Colindale, United Kingdom., Ollinger T; GSK, Wavre, Belgium., Trombetta CM; University of Siena, Department of Molecular and Developmental Medicine, Siena, Italy., Engelhardt OG; National Institute for Biological Standards and Control, Potters Bar, United Kingdom., Caillet C; Sanofi Pasteur, Swiftwater, Pennsylvania, USA.
Publikováno v:
MSphere [mSphere] 2021 Aug 25; Vol. 6 (4), pp. e0056721. Date of Electronic Publication: 2021 Jul 28.
Autor:
Trieu MC; 1The Influenza Centre, Department of Clinical Science, University of Bergen, Bergen, Norway.; 2K.G. Jebsen Centre for Influenza Vaccine Research, Department of Clinical Science, University of Bergen, Bergen, Norway., Zhou F; 1The Influenza Centre, Department of Clinical Science, University of Bergen, Bergen, Norway.; 2K.G. Jebsen Centre for Influenza Vaccine Research, Department of Clinical Science, University of Bergen, Bergen, Norway., Lartey SL; 1The Influenza Centre, Department of Clinical Science, University of Bergen, Bergen, Norway.; 2K.G. Jebsen Centre for Influenza Vaccine Research, Department of Clinical Science, University of Bergen, Bergen, Norway., Sridhar S; 3Jenner Institute, University of Oxford, Oxford, UK.; 6Present Address: Sanofi Pasteur, 1541 Avenue Marcel Mérieux, 69280 Marcy l'Etoile, France., Mjaaland S; 2K.G. Jebsen Centre for Influenza Vaccine Research, Department of Clinical Science, University of Bergen, Bergen, Norway.; 4Department of Infectious Disease Immunology, Norwegian Institute of Public Health, Oslo, Norway., Cox RJ; 1The Influenza Centre, Department of Clinical Science, University of Bergen, Bergen, Norway.; 2K.G. Jebsen Centre for Influenza Vaccine Research, Department of Clinical Science, University of Bergen, Bergen, Norway.; 5Department of Research and Development, Haukeland University Hospital, Bergen, Norway.
Publikováno v:
NPJ vaccines [NPJ Vaccines] 2018 Sep 11; Vol. 3, pp. 45. Date of Electronic Publication: 2018 Sep 11 (Print Publication: 2018).
Autor:
Trieu MC; 1The Influenza Centre, Department of Clinical Science, University of Bergen, Bergen, Norway.; 2K.G. Jebsen Centre for Influenza Vaccine Research, Department of Clinical Science, University of Bergen, Bergen, Norway., Zhou F; 1The Influenza Centre, Department of Clinical Science, University of Bergen, Bergen, Norway.; 2K.G. Jebsen Centre for Influenza Vaccine Research, Department of Clinical Science, University of Bergen, Bergen, Norway., Lartey SL; 1The Influenza Centre, Department of Clinical Science, University of Bergen, Bergen, Norway.; 2K.G. Jebsen Centre for Influenza Vaccine Research, Department of Clinical Science, University of Bergen, Bergen, Norway., Sridhar S; 3Jenner Institute, University of Oxford, Oxford, UK.; 6Present Address: Sanofi Pasteur, 1541 Avenue Marcel Mérieux, 69280 Marcy l'Etoile, France., Mjaaland S; 2K.G. Jebsen Centre for Influenza Vaccine Research, Department of Clinical Science, University of Bergen, Bergen, Norway.; 4Department of Infectious Disease Immunology, Norwegian Institute of Public Health, Oslo, Norway., Cox RJ; 1The Influenza Centre, Department of Clinical Science, University of Bergen, Bergen, Norway.; 2K.G. Jebsen Centre for Influenza Vaccine Research, Department of Clinical Science, University of Bergen, Bergen, Norway.; 5Department of Research and Development, Haukeland University Hospital, Bergen, Norway.
Publikováno v:
NPJ vaccines [NPJ Vaccines] 2018 Aug 14; Vol. 3, pp. 37. Date of Electronic Publication: 2018 Aug 14 (Print Publication: 2018).
Autor:
Olberg HK; Department of Neurology, Haukeland University Hospital, Bergen, Norway.; Department of Clinical Medicine, University of Bergen, Bergen, Norway., Eide GE; Centre for Clinical Research, Haukeland University Hospital, Bergen, Norway.; Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway., Cox RJ; Department of Research and Development, Haukeland University Hospital, Bergen, Norway.; Influenza Centre, Department of Clinical Science, University of Bergen, Bergen, Norway.; KG Jebsen Centre for Influenza Vaccine Research, Department of Clinical Science, University of Bergen, Bergen, Norway., Jul-Larsen Å; Influenza Centre, Department of Clinical Science, University of Bergen, Bergen, Norway.; KG Jebsen Centre for Influenza Vaccine Research, Department of Clinical Science, University of Bergen, Bergen, Norway., Lartey SL; Department of Research and Development, Haukeland University Hospital, Bergen, Norway.; Influenza Centre, Department of Clinical Science, University of Bergen, Bergen, Norway.; KG Jebsen Centre for Influenza Vaccine Research, Department of Clinical Science, University of Bergen, Bergen, Norway., Vedeler CA; Department of Neurology, Haukeland University Hospital, Bergen, Norway.; Department of Clinical Medicine, University of Bergen, Bergen, Norway.; KG Jebsen Centre for MS Research, Department of Clinical Medicine, University of Bergen, Bergen, Norway., Myhr KM; KG Jebsen Centre for MS Research, Department of Clinical Medicine, University of Bergen, Bergen, Norway.; Norwegian Multiple Sclerosis Registry and Biobank, Department of Neurology, Haukeland University Hospital, Bergen, Norway.
Publikováno v:
European journal of neurology [Eur J Neurol] 2018 Mar; Vol. 25 (3), pp. 527-534. Date of Electronic Publication: 2018 Jan 06.
Autor:
Mohn KG; The Influenza Center., Brokstad KA; Broegelmann Research Laboratory, Department of Clinical Science., Pathirana RD; The Influenza Center., Bredholt G; The Influenza Center., Jul-Larsen Å; The Influenza Center., Trieu MC; The Influenza Center., Lartey SL; The Influenza Center., Montomoli E; Department of Molecular and Developmental Medicine, University of Siena VisMederi, Siena, Italy., Tøndel C; Department of Clinical Medicine, University of Bergen Department of Pediatrics., Aarstad HJ; Department of Clinical Medicine, University of Bergen Department of Otolaryngology/Head and Neck Surgery., Cox RJ; The Influenza Center Department of Research & Development, Haukeland University Hospital, Bergen K.G. Jebsen Center for Influenza Vaccines, University of Bergen, Norway.
Publikováno v:
The Journal of infectious diseases [J Infect Dis] 2016 Sep 01; Vol. 214 (5), pp. 722-31. Date of Electronic Publication: 2016 May 30.